Roboticists who attend business conferences don’t always have kind words for humanoid robots. It’s not that walking, talking androids aren’t cool, particularly if one could take the trash out for you. But entrepreneurs and investors in robotics are looking for something far more practical—and profitable—in the near term. Commercial viability and pragmatism was one of the … Continue reading “RoboBusiness: Workhorse Robots, Starter Kits, and Internet of Bots”
Category: Boston
Post-MassChallenge, Healthtech Startup ConsortiEX Growing in WI
Consolidation is the name of the game these days in the healthcare industry, as hospitals, clinics, and private physician groups across the country are increasingly teaming up. While healthcare officials and critics of such mergers and acquisitions might disagree over the real motives behind them, there’s no question that healthcare providers are taking a hard … Continue reading “Post-MassChallenge, Healthtech Startup ConsortiEX Growing in WI”
Shanghai Report: Big Questions About China’s Growth Plans
It only took a few days after I returned from China for my eyes to stop burning, and maybe the slight cough was really due to the changing seasons in Boston and not the air pollution in Shanghai (now I better understand the amenity in my hotel room—see below). A small price to pay to … Continue reading “Shanghai Report: Big Questions About China’s Growth Plans”
ZetrOz Lands $5,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fb62bd73-0d1b-48d3-b38b-00eeab4c373e Date 10/20/2014 Company Name ZetrOz Mailing Address 56 Quarry Rd. Trumbull, CT 06611 USA Company Description ZetrOZ was officially founded in 2009 after a year of work by Co-Founders Bryant Guffey—CEO, George Lewis—CSO and JoAnne Guarino— COO who all met at Cornell University with a passion in science and entrepreneurship. Website … Continue reading “ZetrOz Lands $5,000,000 New Financing”
Portal Instruments Obtains $11,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9ed66b97-a2e3-43b2-8395-67921cf89762 Date 10/18/2014 Company Name Portal Instruments Mailing Address 148 Sidney Street Cambridge, MA 02139 USA Company Description Portal Instruments is a development stage, venture-backed company that is developing a unique platform technology to transform the delivery of modern medicines and improve the patient experience. Website http://www.portalinstruments.com Transaction Type Venture Equity Transaction … Continue reading “Portal Instruments Obtains $11,000,000 Series A Funding Round”
Innovation Hub: Introverts as Innovators
Entrepreneurs, bosses, and leaders are often highly social and extroverted—take Steve Jobs or Richard Branson. They can work a room. They derive energy from being around others. But what if being outgoing and extroverted isn’t actually the key to success in the workplace? Susan Cain, author of Quiet: The Power of Introverts in a World … Continue reading “Innovation Hub: Introverts as Innovators”
Smart Youths Create “Spark” Smartwatch That Keeps People Awake
For folks who fear nodding off on the job or during class, the team at Blanc believes their smartwatch can solve the problem. At last night’s Getgeeked gadget show in New York, CEO Eddy Zhong, a 17-year-old high schooler, showed off his startup’s Spark watch, which detects if someone may be dozing and vibrates to … Continue reading “Smart Youths Create “Spark” Smartwatch That Keeps People Awake”
VC Funding Still Robust as Year-to-Date Total Exceeds 2013
Venture capital activity is down from a 13-year high during the second quarter, but a new MoneyTree Report released today shows that venture funding was still going strong in the three months that ended Sept. 30, with $9.9 billion invested in 1,023 deals. That was almost a 27 percent drop from the $13.5 billion that … Continue reading “VC Funding Still Robust as Year-to-Date Total Exceeds 2013”
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More
After a one-week hiatus, the roundup is back, and we’ve got plenty of news to take your mind off of Ebola, the plunging stock market, and the now-defunct AbbVie-Shire megamerger. Let’s get right to it: —A month after leaving Epizyme for a return to the venture capital world, Jason Rhodes took the helm of a … Continue reading “East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More”
Coalition Aims to Fortify MA Robotics Cluster, Turn Town into Test Bed
Massachusetts wants your robots. Local companies and universities are organizing an “innovation hub” that includes a startup incubator, educational programs, and potentially a whole town to test self-driving cars and drone package delivery in real-world conditions. Central to the effort is MassRobotics, a non-profit designed to grow the robotics industry by fostering collaboration between academia, … Continue reading “Coalition Aims to Fortify MA Robotics Cluster, Turn Town into Test Bed”
Boston Tech Tidbits: Digital Guardian, MassChallenge, Nara, Quantopian
Lots going on in the Boston tech startup scene this week: —Accelerator program MassChallenge announced its top 26 startups that are competing for prize money. The awards ceremony is Oct. 29, and Uber CEO Travis Kalanick is keynoting. —Nara Logics has raised $6 million more from .406 Ventures and other investors. The Cambridge, MA, startup, … Continue reading “Boston Tech Tidbits: Digital Guardian, MassChallenge, Nara, Quantopian”
Joint Harvard-MIT Events to Showcase Innovation Across Energy Spectrum
Having grown up in a small town in eastern North Carolina, going to Harvard for college was more than a dream come true. I still remember from my campus visit feeling my jaw drop as I wandered into the freshman dining hall that looked like the Great Hall straight out of the Harry Potter books. … Continue reading “Joint Harvard-MIT Events to Showcase Innovation Across Energy Spectrum”
Quantopian Secures $15,000,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=483849b2-179d-4eae-8b33-db8807d301f9 Date 10/16/2014 Company Name Quantopian Mailing Address 77 Summer St. 3rd Floor Boston, MA 02110 USA Company Description Quantopian is a platform for you to build, test, and execute trading algorithms. Website http://www.quantopian.com Transaction Type Venture Equity Transaction Amount $15,000,000 Transaction Round Series B Proceeds Purposes With this round of funding, … Continue reading “Quantopian Secures $15,000,000 Series B Funding”
Quantopian Receives $15,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=483849b2-179d-4eae-8b33-db8807d301f9 Date 10/16/2014 Company Name Quantopian Mailing Address 77 Summer St. 3rd Floor Boston, MA 02110 USA Company Description Quantopian is a platform for you to build, test, and execute trading algorithms. Website http://www.quantopian.com Transaction Type Venture Equity Transaction Amount $15,000,000 Transaction Round Series B Proceeds Purposes With this round of funding, … Continue reading “Quantopian Receives $15,000,000 Series B Round”
Is Clean Energy the Sleeper Tech Industry in Boston?
When I step out of the Kendall Square subway stop in Cambridge, MA, on my way to work, it’s hard not to be reminded what a hub for innovation it is. During a short walk, I pass dozens of tech and life sciences companies packed into what’s become the midtown Manhattan of Cambridge. Having covered … Continue reading “Is Clean Energy the Sleeper Tech Industry in Boston?”
Selecta, Sharpening Focus, Gets $20M More to Make Biologics Safer
Selecta Biosciences started up six years ago with a plan to use nanoparticles to make customizable vaccines. Along the way, however, the Watertown, MA-based company found a potentially lucrative niche for its technology—helping to make other biologic drugs on the market safer. Today, it’s cashing a big check from a group of its venture backers … Continue reading “Selecta, Sharpening Focus, Gets $20M More to Make Biologics Safer”
EverTrue Expands, Raises $8M More for Alumni Donor Tools
Perhaps it’s no surprise that a tech company that’s all about alumni fundraising knows how to fundraise itself. Boston startup EverTrue has closed an $8 million Series B financing round led by previous investor Bain Capital Ventures, with some of the money coming from Silicon Valley Bank. The 40-person company has raised a total of … Continue reading “EverTrue Expands, Raises $8M More for Alumni Donor Tools”
EverTrue Secures $8,000,000 Series B Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ed7333c3-b096-4199-bc6f-f7bbf6fcda30 Date 10/15/2014 Company Name EverTrue Mailing Address 330 Congress Street 2nd Floor Boston, MA 02210 USA Company Description We are class officers, alumni club leaders and annual fund volunteers. We are grateful for the generosity of donors who helped fund our education. We are committed to inspiring our peers to support … Continue reading “EverTrue Secures $8,000,000 Series B Financing”
InCrowd Obtains $300,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5f87e85c-ba35-45b5-a18c-629874556cc8 Date 10/15/2014 Company Name InCrowd Mailing Address 222 Third Street Cambridge, MA 02142 USA Company Description InCrowd’s on-demand platform gives you direct and immediate access to Crowds of screened and targeted healthcare professionals – so you can know now. Website http://www.incrowdnow.com Transaction Type Debt Transaction Amount $300,000 Transaction Round Undisclosed Proceeds … Continue reading “InCrowd Obtains $300,000 New Funding”
Qstream Lands $942,500 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9976bf22-0d47-42e6-adf5-a4f90b71d44a Date 10/15/2014 Company Name Qstream Mailing Address 200 Wheeler Road Burlington, MA 01803 USA Company Description Qstream provides a mobile enterprise solution for managing and measuring the capabilities of sales forces in just minutes a day. Developed at Harvard, Qstream’s solution has been scientifically proven in dozens of clinical trials to change behaviors with … Continue reading “Qstream Lands $942,500 New Round”
Nara Logics Garners $6,000,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=06459e48-69b4-40ab-a374-bed154c60fe0 Date 10/15/2014 Company Name Nara Logics Mailing Address 222 Third Street Cambridge, MA 02142 USA Company Description Based in Cambridge, MA, Nara is a team of creative artists, neuroscientists, astrophysicists, computer scientists, and technology and internet industry veterans who grew tired of the web in its current state and decided to … Continue reading “Nara Logics Garners $6,000,000 Series A Funding”
EverTrue Receives $8,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ed7333c3-b096-4199-bc6f-f7bbf6fcda30 Date 10/15/2014 Company Name EverTrue Mailing Address 330 Congress Street 2nd Floor Boston, MA 02210 USA Company Description We are class officers, alumni club leaders and annual fund volunteers. We are grateful for the generosity of donors who helped fund our education. We are committed to inspiring our peers to support … Continue reading “EverTrue Receives $8,000,000 Series B Round”
Selecta Biosciences Secures $20,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c8179754-be09-4f8c-9de7-e8de9bf28c58 Date 10/15/2014 Company Name Selecta Biosciences Mailing Address 480 Arsenal St. Building One Watertown, MA 02472 USA Company Description Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. Website http://www.selectabio.com … Continue reading “Selecta Biosciences Secures $20,000,000 New Funding Round”
CommonAngels Ventures Raises $26.5M Fund in Shifting VC Landscape
There’s a newly raised tech-investment fund in town. Is it an angel fund or a venture fund? A bit of both, actually. But it’s been moving toward the latter. CommonAngels, the Boston-area angel investment group, has closed its fourth fund at $26.5 million. It has also officially changed its name to CommonAngels Ventures. (Disclosure: CommonAngels … Continue reading “CommonAngels Ventures Raises $26.5M Fund in Shifting VC Landscape”
Why It Requires Rocket Engineers to Make Your House Comfortable
There are dozens of startups building various pieces of the “smart home,” but Boston-based Ecovent is starting in unusual place: heating and cooling vents. The company today said it raised $2.2 million from angel investors to speed up production of sensors and vents that make homes more comfortable and energy efficient. The year-old company was … Continue reading “Why It Requires Rocket Engineers to Make Your House Comfortable”
Public Company, Meet Startup: Demandware Snaps Up CQuotient
While most eyes have been on the IPOs of Wayfair and Hubspot this month, it’s good to remember the last batch of Boston-area tech companies that went public. One of them is Demandware, a Burlington, MA-based maker of online shopping software for brands and retailers. The company had its IPO in 2012, and its stock … Continue reading “Public Company, Meet Startup: Demandware Snaps Up CQuotient”
Venture Firms Turn Down Funding Volume, but Still Rockin’ in Q3
Venture capital activity descended from the stratosphere during the third quarter, but it was still flying high, as venture firms invested nearly $9.8 billion in 879 deals across the United States, according to a report released today by the financial data firm CB Insights. The amount invested during the quarter was down 30 percent from … Continue reading “Venture Firms Turn Down Funding Volume, but Still Rockin’ in Q3”
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors
Jason Rhodes has taken the helm of a new startup biotech. And in some ways, it’s a bit like the one he just left, Cambridge, MA-based Epizyme—a developer of cancer drugs. Now the question is whether he can help steer the new one, Raze Therapeutics, towards the billion-dollar valuation Epizyme enjoys today. Fresh off his … Continue reading “With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors”
Biotech Startups Tap Spider Genes in Quest to Spin Silk Gold
A modern-day Silk Road is emerging, and traffic on it is building up. These explorers aren’t traversing routes across continents, but instead are seeking scientific and agricultural alchemy to produce a sort of holy grail in apparel: commercial amounts of spider silk. Spider silk is a multi-purpose fiber able to be transformed into surgical bandages, … Continue reading “Biotech Startups Tap Spider Genes in Quest to Spin Silk Gold”
ecovent Secures $2,200,000 Seed Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f2c12b1d-4add-4864-aeaf-0b34e7b6471c Date 10/14/2014 Company Name ecovent Mailing Address 12 Channel St. Boston, MA 02210 USA Company Description ecovent has developed and proven an integrated, owner-installed system that addresses homeowner frustrations of temperature imbalance between rooms and high energy costs related to heating and cooling homes. Website http://www.ecoventsystems.com Transaction Type Venture Equity Transaction … Continue reading “ecovent Secures $2,200,000 Seed Funding”
Raze Therapeutics Lands $24,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ab924553-dd87-4299-bb48-66f79fd62d62 Date 10/14/2014 Company Name Raze Therapeutics Mailing Address 25 First Street Cambridge, MA 02141 USA Company Description Raze Therapeutics is a biotechnology company dedicated to the discovery and development of a new class of oncology therapeutics that target fundamental metabolic pathways driving cancer growth and survival. Website http://www.razetx.com Transaction Type Venture … Continue reading “Raze Therapeutics Lands $24,000,000 Series A Funding Round”
ecovent Garners $2,200,000 Seed Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f2c12b1d-4add-4864-aeaf-0b34e7b6471c Date 10/14/2014 Company Name ecovent Mailing Address 12 Channel St. Boston, MA 02210 USA Company Description ecovent has developed and proven an integrated, owner-installed system that addresses homeowner frustrations of temperature imbalance between rooms and high energy costs related to heating and cooling homes. Website http://www.ecoventsystems.com Transaction Type Venture Equity Transaction … Continue reading “ecovent Garners $2,200,000 Seed Funding”
Raze Therapeutics Receives $24,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ab924553-dd87-4299-bb48-66f79fd62d62 Date 10/14/2014 Company Name Raze Therapeutics Mailing Address 25 First Street Cambridge, MA 02141 USA Company Description Raze Therapeutics is a biotechnology company dedicated to the discovery and development of a new class of oncology therapeutics that target fundamental metabolic pathways driving cancer growth and survival. Website http://www.razetx.com Transaction Type Venture … Continue reading “Raze Therapeutics Receives $24,000,000 Series A Funding Round”
Gamma Medica Secures $6,500,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ca2db845-16a0-494d-8873-99e008f847b2 Date 10/14/2014 Company Name Gamma Medica Mailing Address 12 Manor Parkway Salem, NH 03079 USA Company Description Gamma Medica, Inc. builds and services imaging systems based on novel technologies to improve patient health through early diagnosis of disease, improved patient treatment and by enabling new drug discovery. Website http://www.gammamedica.com Transaction Type … Continue reading “Gamma Medica Secures $6,500,000 New Funding Round”
Agrivida Garners $1,249,500 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6c9cee53-dbd4-478f-afb1-ee9dd9f0aa31 Date 10/14/2014 Company Name Agrivida Mailing Address 411 Massachusetts Ave Cambridge, MA 02139 USA Company Description Agrivida is developing proprietary crops and processes to transform the economics of producing renewable chemicals, fuels, and bioproducts from non-food cellulosic biomass. The company’s patented approach is designed to provide an integrated solution for delivering … Continue reading “Agrivida Garners $1,249,500 New Funding”
Untying the Knots in Big Data and Big Biology: Q&A with Andrew Su
As big data becomes increasingly important in using genomic information, the National Institutes of Health is funding a sweeping initiative to help untie the knots that make it hard to extract and apply meaningful information from huge biomedical data sets. The program was conceived, in the words of NIH Director Francis Collins, to “overcome the … Continue reading “Untying the Knots in Big Data and Big Biology: Q&A with Andrew Su”
Six Takeaways from Boston’s Life Science Disruptors
Failure isn’t just a possibility in biotech—it’s a probability. Plan accordingly, and don’t let your ego get in the way when you do. It doesn’t matter so much “how” a drug works, as long as it does. And when the inevitable fork in the road comes, don’t be afraid to take the more difficult path—as … Continue reading “Six Takeaways from Boston’s Life Science Disruptors”
How Much Should I Work?
My son, a member of the optimization generation, where pretty much every aspect of his life will be tracked, measured, and ultimately ruled by the Alg, posed a fascinating question to me the other day. He simply asked, “How much should I work?” Now, the context for the question is that he’s undoubtedly a Type … Continue reading “How Much Should I Work?”
Publicize Garners New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3d88a028-ecac-4bdb-9649-fa74d1eca8ce Date 10/13/2014 Company Name Publicize Mailing Address 64 Old Road Westport, CT 06880 USA Company Description Publicize is a startup aiming to disrupt the PR industry. The company was founded in 2010 by Conrad Egusa, a former VentureBeat writer, when he realized that the PR industry’s business model was broken for … Continue reading “Publicize Garners New Funding Round”
Publicize Receives New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3d88a028-ecac-4bdb-9649-fa74d1eca8ce Date 10/13/2014 Company Name Publicize Mailing Address 64 Old Road Westport, CT 06880 USA Company Description Publicize is a startup aiming to disrupt the PR industry. The company was founded in 2010 by Conrad Egusa, a former VentureBeat writer, when he realized that the PR industry’s business model was broken for … Continue reading “Publicize Receives New Funding Round”
Phoodeez Obtains $300,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=45b8f931-199d-43e7-b293-44d8061f26cd Date 10/10/2014 Company Name Phoodeez Mailing Address 179 Lincoln Street 4th Floor Boston, MA 02111 USA Company Description It was late on a weeknight in an MIT Sloan MBA program conference room. Sal Lupoli and Christine Marcus were among 100 other students crunching for finals, and they were hungry. Really hungry, … Continue reading “Phoodeez Obtains $300,000 New Funding Round”
HubSpot in Dublin: Lessons in Building a Global Public Company
The latest U.S. tech company to go public is HubSpot, which has netted about $114 million in its IPO on the New York Stock Exchange. From a global perspective, what’s most interesting about the Boston-area online marketing company (NYSE: [[ticker:HUBS]]) has been its effort to go into new international markets. You’ve heard of founders Dharmesh … Continue reading “HubSpot in Dublin: Lessons in Building a Global Public Company”
Can Salesforce1 Push the Workforce into the Mobile Age?
Dreamforce 2014 is quickly approaching, and it has me thinking about the impact Salesforce (NASDAQ: [[ticker:CRM]]) has had on the way we work and more generally on the future of work itself. Dreamforce is the annual Salesforce user conference, and it has more or less become a must-attend event for anyone in the cloud computing … Continue reading “Can Salesforce1 Push the Workforce into the Mobile Age?”
Online Pharmacy Startup PillPack Lands $8.75M, Led By Accel
A lot of technology startups get rightly criticized for not bothering to tackle a problem that will make anyone’s life better. PillPack is not one of those startups. The Manchester, NH-based company offers a new twist on the concept of a mail-order pharmacy. Instead of sending long-term supplies of drugs in conventional pill bottles, PillPack … Continue reading “Online Pharmacy Startup PillPack Lands $8.75M, Led By Accel”
PillPack Lands $8,750,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b0c4868e-2a10-4471-9780-cb7b294dbeda Date 10/9/2014 Company Name PillPack Mailing Address 250 Commercial St. Manchester, NH 03101 USA Company Description PillPack is pharmacy simplified. We fill, sort, and deliver all your medications in personalized packets based on when you need to take them. Our service helps you take the right meds at the right time, … Continue reading “PillPack Lands $8,750,000 New Funding Round”
HubSpot IPO Raises $114M for Online Marketing Software
Online marketing software seller HubSpot, which helps mid-sized businesses attract customers with blog posts, e-mails, and social media campaigns, has raised about $114 million in its initial public stock offering. The Cambridge, MA-based company said Wednesday night that it sold 5 million shares of its stock at $25 each. That price was higher than HubSpot’s previously estimated price range, indicating … Continue reading “HubSpot IPO Raises $114M for Online Marketing Software”
OpenView Venture Partners Raises $250 Million Fund
Boston’s OpenView Venture Partners, a VC firm that backs growth-stage software companies, has raised $250 million for its fourth fund. The news was expected. Fortune reported in August that OpenView was hoping to hit that price tag for the new fund, which had been teased in an SEC filing. OpenView touts several successful investments, including Intel-acquired API service Mashery and marketing software seller … Continue reading “OpenView Venture Partners Raises $250 Million Fund”
Thync Adds Brain Electrodes to the Mix in Mobile Health Wearables
Khosla Ventures has been staking out a notable claim in the mobile health field by investing in companies that track physical activity, vital signs, social interactions, eye functioning, and even the chemicals released in a user’s breath. Now, another one of the VC firm’s companies is hoping to take things a little further. Rather than … Continue reading “Thync Adds Brain Electrodes to the Mix in Mobile Health Wearables”
What Seattle Needs (Part 3): Working Together to Revitalize Biotech
These are incredibly exciting times in biomedical research. Though the biopharmaceutical industry is in flux, prospects for a greater understanding of the disease process, and the development of new treatments, has never been brighter. Gilead Sciences’s new hepatitis C drug sofosbuvir (Sovaldi) will actually cure most patients of their infections, and replaces treatments that were … Continue reading “What Seattle Needs (Part 3): Working Together to Revitalize Biotech”
After Going Dark, GMZ Energy Plots a Comeback on Waste Heat
GMZ Energy made a bet on solar energy and lost. Now, its fortunes lie in convincing industrial companies to put its power-producing devices into their products. The Waltham, MA-based company traces its roots back to the labs of MIT and Boston College where researchers developed ways to improve the performance of thermoelectrics—materials that produce electricity … Continue reading “After Going Dark, GMZ Energy Plots a Comeback on Waste Heat”